SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment [Yahoo! Finance]
SELLAS Life Sciences Group, Inc. (SLS)
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm
Check Earnings Report
US:NYSE Investor Relations:
sellaslifesciences.com/investors/overview/default.aspx
Company Research
Source: Yahoo! Finance
Executive Officer Angelos Stergiou reiterated that 2026 is poised to be a pivotal year for Sellas Life Sciences Group Inc. (NASDAQ:SLS). The remarks align with the significant progress the company is making in its key GPS and SLS009 clinical programs. SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment Copyright: dolgachov / 123RF Stock Photo The company is moving towards the final analysis of the Phase 3 REGAL trial of GPS in AML patients following second-line salvage therapy. Positive REGAL trial results could position it as the first and best-in-class immunotherapeutic option in this AML population. Sellas Life Sciences is also making significant progress in developing the SLS009 clinical program for AML. Following positive Phase 2 results in high-risk molecular subtypes, the company has started dosing the first patient in the expansion cohort. Preclinical data in T-PLL demonstrated a statistically significant survival benefit for S
Show less
Read more
Impact Snapshot
Event Time:
SLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLS alerts
High impacting SELLAS Life Sciences Group, Inc. news events
Weekly update
A roundup of the hottest topics
SLS
News
- SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run [Yahoo! Finance]Yahoo! Finance
- SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths [Yahoo! Finance]Yahoo! Finance
- SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
SLS
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/20/26 - Form S-3ASR
- 3/19/26 - Form 8-K
- SLS's page on the SEC website